Larson Financial Group LLC

Position in HLN — Haleon plc

CIK 1731061 ST LOUIS, MO

Position in HLN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$122,362

+$8,150 QoQ

Shares Held

12,224

+8.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

15 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Larson Financial Group LLC holds $2,020,512 across 41 Drug Manufacturers - Specialty & Generic names. HLN ranks #5 (6.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	6,129	$724,509
2	NBIX	Neurocrine Biosciences Inc	1,542	$203,143
3	TAK	Takeda Pharmaceutical Co Ltd	7,759	$143,696
4	HIMS	Hims & Hers Health, Inc.	6,697	$139,029
5	HLN	Haleon plc This page	12,224	$122,362
6	LNTH	Lantheus Holdings, Inc.	1,453	$110,210
7	UTHR	UNITED THERAPEUTICS Corp	181	$107,329
8	HROW	Harrow, Inc.	2,277	$80,287

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$122,362	12,224	+8.2%	Shares	Sole	2026-05-15
2025-12-31	$114,212	11,297	+542.2%	Shares	Sole	2026-02-06
2025-09-30	$15,778	1,759	-56.2%	Shares	Sole	2025-11-14
2025-06-30	$41,635	4,015	+330.3%	Shares	Sole	2025-08-08
2025-03-31	$9,600	933	-16.4%	Shares	Sole	2025-05-02
2024-12-31	$10,646	1,116	-2.5%	Shares	Sole	2025-02-07
2024-09-30	$12,114	1,145	+104.8%	Shares	Sole	2024-11-12
2024-06-30	$4,617	559	-56.9%	Shares	Sole	2024-08-02
2024-03-31	$11,020	1,298	+117.1%	Shares	Sole	2024-05-03
2023-12-31	$4,921	598	0.0%	Shares	Sole	2024-02-01
2023-09-30	$4,981	598	+100.7%	Shares	Sole	2023-11-03
2023-06-30	$2,497	298	-62.0%	Shares	Sole	2023-08-03
2023-03-31	$6,389	785	+164.3%	Shares	Sole	2023-05-04
2022-12-31	$2,376	297	0.0%	Shares	Sole	2023-02-03
2022-09-30	$1,808	297	—	Shares	Sole	2022-11-03
No filing history on record for this holder in this stock.